Brief: Kancera: Drug Candidate KAND567 Gives Positive Effect On Movement Ability In Preclinical Model Of Spinal Cord Injury

Novakand Pharma AB

12/06/2020 07:48

June 12 (Reuters) - Kancera AB  KANC.ST :
    * DRUG CANDIDATE KAND567 GIVES POSITIVE EFFECT ON MOVEMENT
ABILITY
IN PRECLINICAL MODEL OF SPINAL CORD INJURY
    * INTENDS TO APPLY TO CONDUCT PHASE II CLINICAL TRIAL ON
MYOCARDIAL INFARCTION PATIENTS DURING THE LATTER PART OF 2020

Source text for Eikon:  ID:nWkrqDRHF 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))